Ravi Ramessur, Mark Corbett, David Marshall, Marcio L Acencio, Ines A Barbosa, Nick Dand, Paola Di Meglio, Salma Haddad, Andreas H M Jensen, Witte Koopmann, Satveer K Mahil, Marek Ostaszewski, Seher Rahmatulla, Joe Rastrick, Jake Saklatvala, Stephan Weidinger, Kath Wright, Kilian Eyerich, Matladi Ndlovu, Jonathan N Barker, Lone Skov, Curdin Conrad, Catherine H Smith
BACKGROUND: Identification of those at risk of more severe psoriasis and/or associated morbidities offers opportunity for early intervention, reduced disease burden and more cost-effective healthcare. Prognostic biomarkers of disease progression have thus been the focus of intense research, but none are part of routine practice. OBJECTIVES: To identify and catalogue candidate biomarkers of disease progression in psoriasis for the translational research community...
October 2022: British Journal of Dermatology